Yu Cai is the Head of Intellectual Property, Assistant General Counsel at Fate Therapeutics, where she oversees all aspects of IP protection and management across the company. With a unique combination of technical expertise and legal experience, Dr. Cai has led Fate’s IP practice for nearly a decade, building a proven track record in developing and executing global IP strategies, initiating and expanding high-value IP portfolios, guiding global patent prosecution, defending against third-party challenges, and advising on competitive landscape, freedom-to-operate, IP enforcement, and risk mitigation. Before joining Fate Therapeutics, Dr. Cai practiced IP law at Polsinelli, PC, where she served corporations in biotechnology and life sciences industries. She holds a Ph.D. in Plant Sciences and Genetics from the University of Arizona, specializing in epigenetics, as well as a M.S. in Biochemistry and Molecular Biology, and a B.S. in Biochemical Engineering. Dr. Cai obtained her J.D. from the Sandra Day O’Connor College of Law, Arizona State University.
